MDXG FY 2024 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$684M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$349M+8.5% YoY

Gross Profit

$289M82.8% margin

Operating Income

$59M16.9% margin

Net Income

$42M12.2% margin

EPS (Diluted)

$0.28

Cash Flow

Operating Cash Flow

$66M

Free Cash Flow

$65M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$264M

Total Liabilities

$71M

Stockholders' Equity

$193M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$349M	$321M	+8.5%
Gross Profit	$289M	$267M	+8.2%
Operating Income	$59M	$37M	+58.6%
Net Income	$42M	$67M	-37.1%